Suche
Ihre Suche nach "%2A" ergab 64 Treffer
- zur Zurwiesch, JS; Pudelski, N; Hoepner, L et al.
- "Real-Life" Comparison of Pegylated-Interferon 2a Versus 2b Combination Therapy of Chronic Hepatitis C Virus
- HEPATOLOGY. Bd. 53. H. 4. 2011 S. 1405-1406
- Loquai, C; Nashan, D; Hensen, P et al.
- Safety of pegylated interferon-alpha-2a in adjuvant therapy of intermediate and high-risk melanomas.
- Eur J Dermatol. Bd. 18. H. 1. 2008 S. 29-35
- Freitag, Christine M.; Agelopoulos, Konstantin; Huy, Ellen et al.
- Adenosine A(2A) receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder
- EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. Bd. 19. H. 1. 2010 S. 67 - 74
- Zehnter, E; Mauss, S; Boeker, K et al.
- EFFICACY AND TOLERABILITY OF PEGINTERFERON ALPHA-2A (40KD) AND RIBAVIRIN IN RELAPSE-PATIENTS UNDER REAL-LIFE CONDITIONS
- HEPATOLOGY. Bd. 52. H. 4. 2010 S. 799A-800A
- Mauss, S; Schober, A; Lutz, T et al.
- Predictive Factors of Thrombocytopenia in Treatment of Chronic Hepatitis C (CHC) Patients With Peginterferon Alfa-2a (40KD) and Ribavirin
- GASTROENTEROLOGY. Bd. 140. H. 5. 2011 S. S948-S948
- Mauss, S; Schober, A; Lutz, T et al.
- PREDICTIVE FACTORS OF THROMBOCYTOPENIA IN TREATMENT OF CHRONIC HEPATITIS C (CHC) PATIENTS WITH PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN
- JOURNAL OF HEPATOLOGY. Bd. 54. 2011 S. S185-S185
- Beyer, Sarah R.; Mallmann, Robert T.; Jaenecke, Isabel et al.
- Identification of cysteine residues in human cationic amino acid transporter hCAT-2A that are targets for inhibition by N-ethylmaleimide
- The journal of biological chemistry. Bd. 288. H. 42. Bethesda, Md.: Soc. 2013 S. 30411 - 30419
- Sulkowski, Mark S.; Bourliere, Marc; Bronowicki, Jean-Pierre et al.
- Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial
- HEPATOLOGY. Bd. 57. H. 6. 2013 S. 2155-2163
- Sulkowski, Mark S.; Asselah, Tarik; Lalezari, Jacob et al.
- Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic genotype1 HCV: SILEN-C1 trial
- HEPATOLOGY. Bd. 57. H. 6. 2013 S. 2143-2154
- Frank-Raue, K; Rybicki, LA; Erlic, Z et al.
- Risk Profiles and Penetrance Estimations in Multiple Endocrine Neoplasia Type 2A Caused by Germline RET Mutations Located in Exon 10
- HUMAN MUTATION. Bd. 32. H. 1. 2011 S. 51-58
- Siebels, M; Rohrmann, K; Oberneder, R et al.
- A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX(A (R))) and interferon-alpha-2a in metastatic renal cell carcinoma patients
- WORLD JOURNAL OF UROLOGY. Bd. 29. H. 1. 2011 S. 121-126
- Frank-Raue, K; Rybicki, LA; Erlic, Z et al.
- Risk profiles and penetrance estimations in mutliple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10
- Hum Mutat. 2010 S. 1
- Schaefer, M; Sarkar, R; Knop, V et al.
- Escitalopram for the Prevention of Peginterferon-alpha 2a-Associated Depression in Hepatitis C Virus-Infected Patients Without Previous Psychiatric Disease A Randomized Trial
- ANNALS OF INTERNAL MEDICINE. Bd. 157. H. 2. 2012 S. 94-+
- Rossol, S; Schuchmann, M; Mauss, S et al.
- PHARMAECONOMIC EVALUATION OF CHRONIC HCV TREATMENT WITH PEGINTERFERON ALFA-2A/RIBAVIRN - REAL LIFE SETTING IN A LARGE GERMAN COHORT OF 1147 PATIENTS
- HEPATOLOGY. Bd. 54. 2011 S. 858A-859A
- Niederau, Claus; Mauss, Stefan; Schober, Andreas et al.
- Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon alpha-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3
- PLOS ONE. Bd. 9. H. 9. 2014
- Dieterich, Douglas; Asselah, Tarik; Guyader, Dominique et al.
- SILEN-C3, a Phase 2 Randomized Trial with Faldaprevir plus Pegylated Interferon alpha-2a and Ribavirin in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients
- ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. Bd. 58. H. 6. 2014 S. 3429-3436
- Larrey, D; Lohse, AW; de Ledinghen, V et al.
- Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin
- JOURNAL OF HEPATOLOGY. Bd. 57. H. 1. 2012 S. 39-46
- Huesken, A. C.; Tsianakas, A.; Hensen, P. et al.
- Comparison of pegylated interferon alpha-2b plus psoralen PUVA versus standard interferon alpha-2a plus PUVA in patients with cutaneous T-cell lymphoma
- JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. Bd. 26. H. 1. 2012 S. 71-78
- Boeker, K; Mauss, S; Zehnter, E et al.
- SVR AND ANEMIA IN HCV-GENOTYPE 1 PATIENTS TREATED WITH PEG-INTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV): LITTLE EFFECT OF RIBAVIRIN DOSAGE
- HEPATOLOGY. Bd. 52. H. 4. 2010 S. 768A-769A
- Christensen, Stefan; Boeker, Klaus H.; Eisenbach, Christoph et al.
- Efficacy and safety of eRVR patients treated with telaprevir, peginterferon alfa-2A and ribavirin: SVR Data from the German non-interventional PAN Study
- HEPATOLOGY. Bd. 58. 2013 S. 1127A-1127A
- Hueppe, D; Zehnter, E; Mauss, S et al.
- Efficacy and Tolerability of Peginterferon Alfa-2a (40KD) (PEG) and Ribavirin (RBV) in Genotype 5 and 6 Patients with Chronic Hepatitis C Under Real Life Conditions
- GASTROENTEROLOGY. Bd. 136. H. 5. 2009 S. A839-A840
- Lohse, AW; Böcher, WO; Biesterfeld, S et al.
- Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation
- Transpl Int. Bd. 20. 2007 S. 583-590
- Zimmermann, Tim; Hueppe, Dietrich; Mauss, Stefan et al.
- Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naive Patients Infected with Hepatitis C Virus Genotype 1
- JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES. Bd. 25. H. 1. 2016 S. 15-24
- Mauss, S.; Boeker, K. H. W.; Eisenbach, C. et al.
- REAL-WORLD EFFICACY AND SAFETY OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON alfa-2a AND RIBAVIRIN: INTERIM ANALYSIS FROM THE GERMAN NON-INTERVENTIONAL PAN STUDY
- JOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S357-S358
- Christensen, S.; Mauss, S.; Eisenbach, C. et al.
- WEEK 4 AND 12 EFFICACY OF TELAPREVIR (TVR) IN COMBINATION WITH PEGINTERFERON alfa 2a/RIBAVIRIN (P/R) IN TREATMENT EXPERIENCED PATIENTS WITH GT-1 UNDER REAL LIFE CONDITIONS
- JOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S329-S329